Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Cash & Equivalents (2016 - 2025)

Cryoport (CYRX) has disclosed Cash & Equivalents for 14 consecutive years, with $250.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 636.68% to $250.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $250.5 million, a 636.68% increase, with the full-year FY2025 number at $250.5 million, up 636.68% from a year prior.
  • Cash & Equivalents was $250.5 million for Q4 2025 at Cryoport, down from $255.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $255.8 million in Q3 2025 to a low of $23.9 million in Q1 2021.
  • A 5-year average of $79.1 million and a median of $38.9 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 78.98% in 2022, then skyrocketed 715.57% in 2025.
  • Cryoport's Cash & Equivalents stood at $139.1 million in 2021, then crashed by 78.98% to $29.2 million in 2022, then surged by 58.54% to $46.3 million in 2023, then dropped by 26.63% to $34.0 million in 2024, then surged by 636.68% to $250.5 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Cash & Equivalents are $250.5 million (Q4 2025), $255.8 million (Q3 2025), and $243.4 million (Q2 2025).